Cornercap Investment Counsel’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-38,436
Closed -$808K 598
2022
Q2
$808K Sell
38,436
-262
-0.7% -$5.35K 0.14% 314
2022
Q1
$909K Sell
38,698
-307
-0.8% -$7.51K 0.1% 356
2021
Q4
$1.06M Sell
39,005
-1,378
-3% -$36.9K 0.15% 270
2021
Q3
$1.15M Buy
+40,383
New +$1.23M 0.13% 259
2019
Q2
Sell
-27,095
Closed -$736K 456
2019
Q1
$736K Buy
27,095
+1,230
+5% +$41.2K 0.1% 344
2018
Q4
$854K Buy
25,865
+1,720
+7% +$69.2K 0.13% 267
2018
Q3
$1.13M Buy
24,145
+6,515
+37% +$299K 0.15% 198
2018
Q2
$763K Buy
+17,630
New +$845K 0.11% 294

Other funds holding MD

Cornercap Investment Counsel's MD Position: Q3 2022 in Review

Cornercap Investment Counsel sold out of Pediatrix Medical (MD) in Q3 2022, closing a stake of 38,436 shares — an estimated $808K sold.

Cornercap Investment Counsel first reported a position in MD in Q2 2018 and held it in 8 quarters. The position peaked at $1.15M in Q3 2021. 211 funds tracked by Wall St. Rank hold MD as of Q3 2022.

  • Cornercap Investment Counsel reported no remaining Pediatrix Medical position as of Q3 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 38,436 Pediatrix Medical shares in Q3 2022, an estimated $808K.
  • Cornercap Investment Counsel first reported a position in Pediatrix Medical in Q2 2018 and held it in 8 quarters.
  • Cornercap Investment Counsel's Pediatrix Medical position peaked at $1.15M in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2022.

Based on Cornercap Investment Counsel's 13F filing for Q3 2022, filed 14 Nov 2022.